In the lung squamous cell carcinoma samples, although there was a similar, but less robust, distribution trend of pathological stages from TSPX-low to TSPX-high groups as in the lung adenocarcinoma samples (Figure 1G), there was also no significant difference in survival rate between TSPX-low group and TSPX-high group (Figure 1H). Here, TSPYL2 is linked to lung adenocarcinoma.